Leigh Zawel - 15 Oct 2021 Form 4 Insider Report for Cullinan Oncology, Inc. (CGEM)

Signature
/s/ Jeffrey Trigilio, Attorney-in-Fact
Issuer symbol
CGEM
Transactions as of
15 Oct 2021
Transactions value $
-$489,350
Form type
4
Filing time
18 Oct 2021, 16:15:20 UTC
Previous filing
12 Oct 2021
Next filing
15 Feb 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CGEM Common Stock Sale -$489K -19.6K -34.43% $25.00 37.3K 15 Oct 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on April 26, 2021.

Remarks:

Chief Scientific Officer, Small Molecules